Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV710
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,451
Award facts
- Contract value 100% obligated
- $39,450.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,450.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials on January 21, 2026, with an ultimate completion date of January 22, 2026. This is a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and other military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that specializes in supplying brand-name and generic medications, vaccines, and medical supplies to federal agencies. The company maintains significant relationships with DLA for delivering diverse pharmaceutical products across multiple therapeutic domains, including diabetes medications like Ozempic. This particular delivery order represents a routine fulfillment of pharmaceutical needs under the existing prime vendor contract that enables the military healthcare system to obtain critical medications efficiently through a pre-established vehicle rather than individual competitive procurements.
Quick answers
Who was awarded contract SPE2DR26FV710?
SPE2DR26FV710 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV710 worth?
The government has obligated $39,451 on SPE2DR26FV710.
Is contract SPE2DR26FV710 an order under another contract?
Yes. SPE2DR26FV710 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV710 competed?
The extent of competition for SPE2DR26FV710 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award